menu search

CFRX / Why Is ContraFect (CFRX) Stock Down 80% Today?

Why Is ContraFect (CFRX) Stock Down 80% Today?
A Phase 3 trial of ContraFect's treatment for antibiotic-resistant infections has been stopped, and CFRX stock is plunging. The post Why Is ContraFect (CFRX) Stock Down 80% Today? Read More
Posted: Jul 14 2022, 11:10
Author Name: InvestorPlace
Views: 111127

CFRX News  

Why Is ContraFect (CFRX) Stock Up 23% Today?

By InvestorPlace
October 16, 2023

Why Is ContraFect (CFRX) Stock Up 23% Today?

ContraFect (NASDAQ: CFRX ) stock is rising higher on Monday as investors react to an update from the Food and Drug Administration (FDA). The FDA has more_horizontal

ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023

By GlobeNewsWire
June 8, 2023

ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023

YONKERS, N.Y., June 08, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discover more_horizontal

Why Is ContraFect (CFRX) Stock Down 14% Today?

By InvestorPlace
April 18, 2023

Why Is ContraFect (CFRX) Stock Down 14% Today?

ContraFect (NASDAQ: CFRX ) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange. That notice has to do with the c more_horizontal

Why Is ContraFect (CFRX) Stock Up 20% Today?

By InvestorPlace
January 31, 2023

Why Is ContraFect (CFRX) Stock Up 20% Today?

ContraFect (NASDAQ: CFRX ) stock is rising higher on Tuesday as investors await news about its potential delisting from the Nasdaq Capital Market. Con more_horizontal

Why Is ContraFect (CFRX) Stock Down 23% Today?

By InvestorPlace
January 27, 2023

Why Is ContraFect (CFRX) Stock Down 23% Today?

ContraFect (NASDAQ: CFRX ) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market. more_horizontal

Why Is ContraFect (CFRX) Stock Down 80% Today?

By InvestorPlace
July 14, 2022

Why Is ContraFect (CFRX) Stock Down 80% Today?

A Phase 3 trial of ContraFect's treatment for antibiotic-resistant infections has been stopped, and CFRX stock is plunging. The post Why Is ContraFect more_horizontal


Search within

Pages Search Results: